試す 金 - 無料
“We plan to enter India, Japan, Thailand, and Vietnam to improve the safety of researchers”
BioSpectrum Asia
|BioSpectrum Asia August 2025
As biotech research laboratories, in both industry and academic settings, engage in increasingly complex projects worldwide, ensuring the safety of personnel, equipment, and the surrounding environment becomes paramount.
Beyond the immediate health impacts, accidents can disrupt the scientific process, leading to data loss, damage to expensive equipment, and significant delays in research progress. Focusing on these critical aspects, South Korea-based startup Connietec has developed innovative solutions that were launched during the recently held ICPI Week 2025 event in South Korea. BioSpectrum Asia spoke with Aden (Seong-Ho) Do, Chief Executive Officer of Connietec, to find out more about the startup's new product line addressing lab safety. Edited excerpts:
Which are the new products launched by Connietec at the ICPI Week 2025?
ConnieTOP, which was released in ICPI Week 2025, is a safety cap system that prevents or purifies fume volatilisation of organic solvents and waste liquid when operating instrument by connecting with analysis instrument such as liquid chromatography that uses a lot of organic solvents such as methanol and acetonitrile, so that it can protect the environment of the laboratory and the health of the researchers and achieve reproducible experimental results.
First, the solvent bottle safety cap (CT-SSC, Solvent Safety Cap) uses a filter designed to prevent the solvent from volatilising out of the solvent bottle when the solvent flows into the analysis instrument, and this filter (CT-CVF12M, Check Valve for 12 Months) applies a PE-based Frit that is different from other companies' membrane filter types, increasing the recommended usage period to about one year compared to six months of other companies’ products, which can be managed at a lower maintenance cost.
このストーリーは、BioSpectrum Asia の BioSpectrum Asia August 2025 版からのものです。
Magzter GOLD を購読すると、厳選された何千ものプレミアム記事や、10,000 以上の雑誌や新聞にアクセスできます。
すでに購読者ですか? サインイン
BioSpectrum Asia からのその他のストーリー
BioSpectrum Asia
India Health Fund supports D-Nome to bolster molecular TB screening in India
India Health Fund (IHF), a Tata Trusts initiative, is poised to transform tuberculosis (TB) screening at scale by enabling the development of the world's most affordable molecular screening tool for TB.
1 min
BioSpectrum Asia May 2026
BioSpectrum Asia
BioOra and Octane Biotech sign LoI to expand cell therapy manufacturing using Cocoon Platform
BioOra, a commercialstage cell therapy company advancing CAR-T therapies for cancer patients, & Canadabased Octane Biotech Inc., an Octane Medical Group Company, has announced the signing of a Letter of Intent (LOI) to collaborate on the co-development & deployment of advanced cell therapies using the Cocoon automated cell therapy manufacturing platform.
1 min
BioSpectrum Asia May 2026
BioSpectrum Asia
NTU and NHG Health partner to advance healthcare education in Singapore
NHG Health's inaugural E3 (Educate, Elevate, Evolve) conference, held recently, was marked by a new partnership with Nanyang Technological University (NTU) Singapore, signalling a significant step in advancing healthcare education through interdisciplinary collaboration.
1 min
BioSpectrum Asia May 2026
BioSpectrum Asia
Gene Solutions introduces non-invasive prenatal screening technology triSure in Taiwan
Singapore-based startup Gene Solutions has introduced triSure, a revolutionary non-invasive prenatal screening technology.
1 min
BioSpectrum Asia May 2026
BioSpectrum Asia
How FemTech Spurt in APAC is Redefining Healthcare
Despite representing half the global population, women's health has historically received only a fraction of healthcare innovation and investment.
4 mins
BioSpectrum Asia May 2026
BioSpectrum Asia
China's Colossal Ageing Population and Low Birth Rate Challenge
China's recent policy initiatives pertaining to long-term care insurance, maternity insurance expansion, and primary healthcare reform reflect a coordinated attempt to address deep structural demographic challenges—most notably 'rapid population ageing' and declining birth rates.
2 mins
BioSpectrum Asia May 2026
BioSpectrum Asia
"We need to prioritise research as several common AYA cancers are significantly under-studied in Asian populations"
At the SingHealth Presidents' Scientific and Partners in Social-care (SPSOC) Conference, Assistant Professor Eileen Poon, Senior Consultant in Medical Oncology at the National Cancer Centre Singapore (NCCS) delivered an enlightening presentation.
7 mins
BioSpectrum Asia May 2026
BioSpectrum Asia
Shimadzu Scientific Instruments opens laboratory in San Francisco Bay Area
Shimadzu Scientific Instruments (SSI) has opened its new research and development (R&D) facility in South San Francisco, California, US.
1 min
BioSpectrum Asia May 2026
BioSpectrum Asia
"Building a lean team with deep operational expertise increases likelihood of success in rare disease drug development"
More than 300 million people worldwide are impacted by over 10,000 rare diseases, i.e. more than cancer and AIDS combined.
5 mins
BioSpectrum Asia May 2026
BioSpectrum Asia
Qiagen expands into bloodstream infection syndromic testing with new rapid QIAstat-Dx panel
Qiagen N.V. has announced its expansion into syndromic testing for bloodstream infections with the launch of the CE-IVDR-certified QIAstat-Dx BCID GPF Plus AMR Panel.
1 min
BioSpectrum Asia May 2026
Listen
Translate
Change font size

